Microbicidal paint was used in the oncology unit of Northside Hospital Healthcare System facility in Cummings, ga., according to a case study on from Sherwin-Williams Paint Shield.
The microbicidal properties of the paint were attractive given the compromised immune system of the patient population.
Paint Shield is the first EPA-registered microbicidal paint and kills greater than 99.9 percent of Staph (Staphylococcus aureus), MRSA (Methicillin-resistant Staphylococcus aureus), E. coli (Escherichia coli), VRE (Vancomycinresistant Enterococcus faecalis) and Enterobacter aerogenes within two hours of exposure on the painted surface, according to the case study.
Hospitals Are Energy Super-Users. Why Is It So Hard to Modernize Them?
Encompass Health Rehabilitation Hospital of Bangor Officially Opens
Early Entry: Manager's Critical Role in Construction Planning
The Evolution of Lighting in Patient Care
HealthPartners and Essentia Health to Combine Organizations